Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Belli

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|October 31, 1996
Hepatitis G virus and post-transplantation hepatitisL S Belli, G Idéo, E Silini
Alimentary Pharmacology & Therapeutics|November 12, 2013
Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patientsA Mancuso, C Zavaglia, F Bai, et al.
The American Journal of Gastroenterology|April 1, 1997
Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infectionC Zavaglia, L S Belli, A B Alberti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2020
COVID-19-related thrombotic microangiopathy in a cirrhotic patientA Airoldi, G Perricone, S De Nicola, et al.
Histopathology|April 1, 1991
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlationI O Ng, A K Burroughs, K Rolles, et al.
Clinical Nephrology|July 1, 1986
Immunophenotyping of mononuclear cell infiltrates associated with renal diseaseC Brunati, B Brando, R Confalonieri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver TransplantationP A Cortesi, L Mantovani, A Ciaccio, et al.
Lancet (London, England)|February 6, 1993
Recurrent HCV hepatitis after liver transplantationL S Belli, A Alberti, G F Rondinara, et al.
Contributions to Nephrology|January 1, 1986
Ciclosporin does not inhibit the early steps of lymphocyte activationB Brando, G Civati, G Busnach, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2015
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent HepatitisP A Cortesi, L G Mantovani, A Ciaccio, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|October 31, 1996
Hepatitis G virus and post-transplantation hepatitisL S Belli, G Idéo, E Silini
Alimentary Pharmacology & Therapeutics|November 12, 2013
Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patientsA Mancuso, C Zavaglia, F Bai, et al.
The American Journal of Gastroenterology|April 1, 1997
Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infectionC Zavaglia, L S Belli, A B Alberti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 10, 2020
COVID-19-related thrombotic microangiopathy in a cirrhotic patientA Airoldi, G Perricone, S De Nicola, et al.
Histopathology|April 1, 1991
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlationI O Ng, A K Burroughs, K Rolles, et al.
Clinical Nephrology|July 1, 1986
Immunophenotyping of mononuclear cell infiltrates associated with renal diseaseC Brunati, B Brando, R Confalonieri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver TransplantationP A Cortesi, L Mantovani, A Ciaccio, et al.
Lancet (London, England)|February 6, 1993
Recurrent HCV hepatitis after liver transplantationL S Belli, A Alberti, G F Rondinara, et al.
Contributions to Nephrology|January 1, 1986
Ciclosporin does not inhibit the early steps of lymphocyte activationB Brando, G Civati, G Busnach, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 19, 2015
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent HepatitisP A Cortesi, L G Mantovani, A Ciaccio, et al.
Pageof 6